No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Shenzhen Hepalink Halt.....

Well Shenzhen Hepalink Stock is still halted after all this time and at the same time we hear very little from the Zen3694 trial other than a few gambit of info from the Bio prezzy,  (not much details though)  I am wondering if a deal is being worked on between these 2  ( a deal has ben made with Hepalink and RVX so why not Zenith....) I realize it is all speculation but it is a possibility,    The longer the halt the more I think it is possible.  But maybe they ahve a deal in the works with another biotech... 

Share
New Message
Please login to post a reply